Homologous Recombination Repair Status as a Biomarker of Response in Locally Recurrent/Metastatic Triple Negative Breast Cancer Patients Treated With Concurrent Cisplatin and Radiation Therapy
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Locally Recurrent/Metastatic Triple Negative Breast Cancer
Interventions: RADIATION: external beam radiation therapy|DRUG: cisplatin|PROCEDURE: Biopsy of Target Tumor
Sponsor: Memorial Sloan Kettering Cancer Center
Collaborators: Cedars-Sinai Medical Center